The dose characteristics of low kV intraoperative x-ray source using Gafchromic EBT 3 film
Keywords:
INTRABEAM, Intraoperative irradiation: IORT, Low kV X-Ray source, Lead Sheet Shielding, isotropyAbstract
Background: The INTRABEAM device is an intraoperative radiotherapy (IORT) system used in conjunction with surgery. It delivers a high radiation dose directly to cancer cells, with the radiation evenly distributed in all directions in a spherical pattern.
Objective: To study the radiation dose distribution characteristics from a 50 kV X-ray source of the INTRABEAM, Intra-Operative radiotherapy (IORT) machine, and the efficiency of radiation absorption of the lead sheet using Gafchromic EBT3 film.
Materials and methods: The experiment is divided into four stages as follows: 1) Creating a calibration curve using Gafchromic EBT3 film. 2) The measured depth dose and the distribution of radiation using Gafchromic EBT3 film. 3) The evaluation of the lead shielding effectiveness on a breast phantom to prevent radiation hazards. 4) The radiation dose measurement around the operating room during radiation delivery using a survey meter.
Results: The results are divided into 4 parts. 1) The calibration curve showed that the optical density (OD) increased linearly with the radiation dose, and then plateaued. The red light spectrum was the most sensitive to radiation, maintaining linearity up to approximately 250 cGy. Therefore, red light was used to read the film in all experiments. 2) The depth dose profile resembled the manufacturer's specifications, with slight deviations near the applicator surface and stabilization at around 1 cm depth. The radiation dose distribution from the applicator cone's center was uniform across all planes along both the X and Y axes, indicating an isotropic radiation pattern. 3) Lead sheets were able to absorb up to 89% of the radiation dose. 4) The highest radiation dose was detected near the INTRABEAM device, with a maximum of 34 mR/hr. The radiation dose decreased with increasing distance, measuring below 1 mR/hr outside the operating room and at the staff positions.
Conclusion: The depth dose measured using Gafchromic EBT3 film is consistent with the depth dose data provided by the manufacturer. The distribution of radiation from the edge of the applicator demonstrates isotropic distribution. The lead sheets have high efficiency in absorbing radiation. The radiation levels around the operating room are within safe limits for personnel operating the device, ensuring safety both inside and outside the operating room during patient treatment.
References
Roland H, Solke V, Marcel M, Jan H. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 1985;56:979–90.
Daniel F, Jan H, Roland H. Breast carcinomas of limited extent: frequency, radiologic-pathologic characteristics, and surgical margin requirements. Cancer 2001;91:647–59.
Ninja A, Heather J, Jean Claude H, Philip P, Henk S, Walter B, et al. Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882. Radiother Oncol 2007;82:265–71.
Jayant V, Michael B, Jeffrey T, Frederik W, Samuele M, Mohammed K, et al. Long-term results of TARGeted intraoperative radiotherapy (Targit) boost during breast-conserving surgery. Int J Radiat Oncol Biol Phys 2011;81:1091–7.
Elena B, Uta T, Grit W, Anke K, Markus B, Marc S, et al. Single-center long-term follow-up after intraoperative radiotherapy as a boost during breast-conserving surgery using low-kilovoltage x-rays. Annals of Surgical Oncology 2010;17:352–8.
Joyce B, Jean D, Hollis M, Ralph D. IORT for breast cancer. Current Clinical Oncology: Intraoperative Irradiation Techniques and Results 1999:521–6.
Georg P, Georg D, Van Limbergen E. The use of the source-skin distance measuring bridge indeed reduces skin telangiectasia after interstitial boost in breast conserving therapy. Radiother Oncol 2005; 7:323–30.
Hammer J, Mazeron JJ, Van Limbergen E.Breast boost—why, how, when...?. Strahlenther Onkol 1999; 175:478–83.
Hammer J, Strnad V. Mammakarzinom V, Pötter R, Kovács G. Stand und Perspektiven der klinischen Brachytherapie. Uni-Med, Hamburg 2004:157–67.
Alexandra R, Richard P, Erik L, Eva B, Tanja K, Claudia F, et al. Long-term results (10 years) of intensive breast conserving therapy including a high-dose and large-volume interstitial brachytherapy boost (LDR/HDR) for T1/T2 breast cancer. Radiother Oncol 2002;63:47–58.
Erik Van L. Indications and technical aspects of brachytherapy in breast conserving treatment of breast cancer. Cancer Radiother 2003;7:107–20.
Anil S, Bahman E, William S, and Tarita O. Intraoperative Radiotherapy With INTRABEAM: Technical and Dosimetric Considerations. Front Oncol 2018;8:00074
Fernando G, Jaroslav S, Rolf B, Thorsten S. Dose distributions of the INTRABEAM electronic brachytherapy system measured with traceable detectors. J inst 2023;18:P07049
Downloads
Published
Versions
- 2024-11-27 (2)
- 2024-11-27 (1)
How to Cite
Issue
Section
License
Copyright (c) 2024 Thai Association of Radiation Oncology
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
บทความที่ได้รับการตีพิมพ์เป็นลิขสิทธิ์ของวารสารมะเร็งวิวัฒน์
ข้อความที่ปรากฏในบทความแต่ละเรื่องในวารสารวิชาการเล่มนี้เป็นความคิดเห็นส่วนตัวของผู้เขียนแต่ละท่านไม่เกี่ยวข้องกับ และบุคคลากรท่านอื่น ๆ ใน สมาคมฯ แต่อย่างใด ความรับผิดชอบองค์ประกอบทั้งหมดของบทความแต่ละเรื่องเป็นของผู้เขียนแต่ละท่าน หากมีความผิดพลาดใดๆ ผู้เขียนแต่ละท่านจะรับผิดชอบบทความของตนเองแต่ผู้เดียว